Recent Articles
Bluebird Bio Stock Is for Long-Term Investors Only
Bluebird bio is worth the risk, if you have the necessary patience to ride any short-term storms. Here's what you need to know about BLUE stock's long-term prospects.
Apple’s Real Growth Isn’t What You Might Think
Apple (AAPL) is getting most of the buzz today after the stock jumped 5% on earnings and drove the company’s market cap to $985 billion, making it the leader in the race to become the first company valued at $1 trillion. iPhone sales were actually below estimates, but the company beat on both earnings and revenue thanks to better-than-expected results in software and services, which grew 31%. It’s abundantly clear that iPhone sales have leveled off. It will always be a big moneymaker for the company, but growth will never be what it was.
Bitcoin Cash: Be Bullish While Everyone Else Is Scared
While 2017 was a banner year for cryptocurrencies, 2018 has been rough. That's OK -- use the dips to stick your toe into bitcoin cash.
3 Sports Gambling Stocks to Bet the House On
There is definitely money to be made from the legalization of sports betting -- and not just from betting on your favorite team. These 3 sports gambling stocks are positioned to prosper from the soon-to-explode trend.
Bigger Upside than the FAANGs
For five years now, investors have been in love with a handful of giant technology stocks. You can call them the Four Horsemen of technology – or make that five or six depending on which names you include. You can also call them by some version of the acronym they have come to be known by. Whatever you call them, these stocks have been and continue to be powerhouses in terms of growth and performance. In fact, stocks in the most common grouping – FAANG – now make up more than 10% of the S&P 500.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
